Status:
COMPLETED
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Breast Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
This study, conducted by the NCI and the George Washington University Medical Center (GWUMC), will examine breast tissue from patients with inflammatory breast cancer (IBC) for tumor markers and facto...
Detailed Description
Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast cancer that disproportionately affects young women. The risk factors and pathogenesis of these tumors are unknown an...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients with inflammatory breast cancer.
- Age greater than 18 years.
Exclusion
Key Trial Info
Start Date :
November 20 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 10 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00646555
Start Date
November 20 2003
End Date
April 10 2012
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GW University Medical Center GW Hospital Center
Washington D.C., District of Columbia, United States, 20037